contrast between the numbers of molecules expressed on the cell surface and in virions suggests that M2 may be partially excluded from budding virus particles.
The M2 protein of influenza A virus (for a review, see reference 22) consists of 97 amino acids (24) and is one of the smallest known transmembrane proteins. M2 belongs to the type I signal-anchor protein class and has been used previously to investigate the structural features responsible for this uncommon topology (37, 38) . The external domain of M2, which consists of approximately 24 N-terminal amino acids (24) , appears to determine the type I signal-anchor topology of M2 and of certain chimeric type II proteins that contain these sequences (37, 38) . M2 is cotranslationally inserted into the rough endoplasmic reticulum membrane via a 19-residue hydrophobic signal-anchor domain (17) , and 54 C-terminal amino acids form the cytoplasmic domain (24) . Recent evidence indicates that the M2 protein forms disulfide-linked dimers, tetramers, and possibly higher-order oligomers and is modified by the addition of palmitate to a cytoplasmic cysteine residue in most influenza A virus strains (15, 48, 54) , but a potential N-linked glycosylation site in the external domain is unused (24, 59) . M2 is transported through the Golgi complex to the surfaces of cells infected with influenza virus or recombinant expression vectors (24, 59) , similar to the pathways traversed by the viral glycoproteins (6) . Large numbers of M2 molecules are present on infected-cell surfaces, with a ratio of approximately two M2 molecules per hemagglutinin (HA) trimer in CV-1 cells (24) , but only a few (-23 to 60) M2 molecules are estimated to be incorporated into each virion (57 contrast between the numbers of molecules expressed on the cell surface and in virions suggests that M2 may be partially excluded from budding virus particles.
Polarized epithelial cells are characterized by the presence of apical and basolateral plasma membrane domains that have distinctive protein and lipid compositions (6) . Polarity is developed by the directional transport of cellular proteins and lipids (1, 6, 25, 26, 33, 53) and maintained by tight junctions that physically separate apical and basolateral domains (52) . Polarized epithelial cells from different tissues, such as hepatocytes (1) , kidney cells (26, 28, 31, 40) , and intestinal cells (25, 33) , utilize distinct pathways of protein sorting and may also differ in the relative amount of signalmediated and bulk flow (default) transport to the cell surface. Although cellular sorting mechanisms are not yet understood, directional transport apparently involves the recognition of intrinsic structural features of targeted molecules by cellular sorting receptors (6) . Newly synthesized proteins are sorted during or immediately after exit from the transGolgi network (11) , when apical and basolateral proteins are incorporated into distinct populations of transport vesicles that contain sorting and/or targeting receptors (55) . Many exogenous proteins, such as viral glycoproteins, are also restricted to specific plasma membrane domains when introduced into polarized cells. The influenza virus glycoproteins, hemagglutinin (HA) and neuraminidase, are restricted to the apical domain of polarized cells infected with influenza virus or virus expression vectors (20, 31, 46) . In contrast, the glycoproteins of vesicular stomatitis virus (40, 46) and ret-INFLUENZA VIRUS M2 POLARITY 5543 proteins indicates that the proteins contain intrinsic structural features recognized by the cellular sorting machinery (20, 46) . It is not known whether positive signals are required for both apical and basolateral transport. Proteins that lack sorting signals presumably would be transported to the cell surface by a default pathway, which has not been conclusively identified in kidney cells. The identification of specific sorting signals should be greatly simplified by finding small proteins that are transported directionally to either apical or basolateral membranes.
The small size and the unusual topology of M2 make it an attractive probe to analyze plasma membrane biogenesis, and the transport and ultrastructural distribution of the M2 protein have not been determined in polarized epithelial cells. Therefore, we wished to determine whether M2 was transported to the surfaces of polarized epithelial cells via a directional pathway. Previous studies have focused on the polarized transport of classical type I or II transmembrane glycoproteins, and the expression of type I signal-anchor proteins in polarized cells has not been reported. In addition, an analysis of M2 expression and localization in polarized cells, which restrict influenza virus glycoprotein expression and virus budding to the apical domain (20, 31, 43, 46) , would be of interest in order to determine whether the site of M2 expression is correlated with the site of virus budding. In this study, we used a monoclonal antibody specific for the external domain of M2 (57) (23) was inserted into the pSC11 vaccinia virus insertion plasmid (9) . TK-143 cells were maintained in DMEM minus 5-bromodeoxyuridine for 18 h and then infected with wild-type vaccinia virus (IHD-J strain; multiplicity of infection [MOII = 1) for 2 h at 37°C. Ten micrograms of pSC11-M2 plasmid DNA and 25 ,g of lipofectin reagent (BRL Life Technologies, Inc., Gaithersburg, Md.) were combined, incubated for 15 min at 20°C, and then added to the infected cells. After 20 h at 37°C, the cells exhibited extensive cytopathology, and virus was harvested by three freeze-thaw cycles followed by brief sonication. Recombinant virus was passaged twice in TK-143 cells incubated with 25 ,ug of 5-bromodeoxyuridine per ml and isolated by three rounds of plaque purification in TK-143 cells incubated with 300 ,ug of X-Gal (5-bromo-4-chloro-3-indolyl-3-D-galactopyranoside) per ml and screened by indirect immunofluorescence and immunoprecipitation assays using M2 antibody.
Immunofluorescence assays. MDCK cells were grown to confluence on 12-mm glass coverslips and infected with influenza virus (MOI = 10) for 1 h at 37°C, and then the inoculum was replaced with DMEM plus 2% newborn calf serum. At intervals postinfection (p.i.), the infected cells were reacted with either M2-or HA-specific antibody ( with a fluorescein-conjugated secondary antibody. Cell surface expression of M2 was detected by 4.5 h p.i. (Fig. 2) , while surface HA was detected as early as 3 h p.i. (data not shown). The apical membranes of virus-infected MDCK cells exhibited a punctate fluorescence pattern after labeling with M2 and HA antibodies. However, the M2 fluorescence pattern appeared to be slightly more diffuse than that observed for HA and extended to the cell periphery, giving cells a polygonal appearance, whereas lower levels of HA fluorescence were observed near regions of cell-cell contact. M2 and HA were also colocalized intracellularly (not shown), although HA was detected earlier than M2, consistent with the time course of protein synthesis.
It was reported previously that influenza virus budding as well as expression of the viral glycoproteins, HA and neuraminidase, are restricted to apical membranes of polarized epithelial cells (20, 31, 43, 46) . Therefore, we wished to examine the kinetics of M2 accumulation on apical and basolateral membranes of influenza virus-infected MDCK cells that were grown on permeable nitrocellulose filters to allow antibody access to either membrane surface. For comparison, we quantitated the binding of the D6 monoclonal antibody, which recognizes an antigen present on basolateral membranes of MDCK cells, to apical and basolateral surfaces and found that 94% of the total D6 binding was restricted to the basolateral domain of MDCK cells. Surface expression of M2 and HA on apical and basolateral surfaces of influenza virus-infected MDCK cells was assayed at intervals from 2 to 10 h p.i. using M2 and HA primary antibodies and 1251I-labeled secondary antibody. We found that the expression of HA on apical surfaces preceded that of M2 by -2 h (Fig. 3) antibody and 90 to 93% of the HA antibody were bound to apical surfaces at 8 to 10 h p.i. Thus, the M2 and HA proteins exhibit similar patterns of polarized expression on apical membranes.
Different transport pathways have been reported for targeting of proteins to apical plasma membranes (6) . Apical proteins in hepatocytes are transported exclusively via an indirect pathway, appearing first on basolateral membranes before being endocytosed and redirected to the apical surface (1). In contrast, intestinal cells appear to use both direct and indirect pathways to the apical surface, depending upon the protein in question (25, 33) . The majority of apical membrane proteins in kidney cells appear to be transported exclusively by a direct pathway that does not involve the basolateral surface (26) (27) (28) 31) , but certain membrane proteins, including the polymeric Ig receptor, are transported to apical surfaces by an indirect pathway when expressed in MDCK cells (3, 35) . Therefore, to examine the kinetics of transport and the initial site of M2 plasma membrane insertion in influenza virus-infected MDCK cells, we used pulse-chase metabolic labeling in conjunction with plasma membrane domain-specific immunoprecipitation and SDSpolyacrylamide gel electrophoresis. For comparison, the transport of the HA protein to apical or basolateral surfaces of infected cells was determined. M2 was first detected on the apical surfaces of influenza virus-infected MDCK cells after a 15-min pulse and 60-min chase (Fig. 4) . The level of apical M2 increased after 2 h, while levels of M2 protein on basolateral membranes were very low at both time points, consistent with the low levels of basolateral M2 detected by 1251I-labeled antibody binding. A fraction of the HA protein was cleaved to HAl and HA2 during transport, and significant levels of both cleaved and uncleaved HA were detected on apical surfaces after 1-h chase. Similar results were obtained using domain-specific biotinylation and streptavidin precipitation (data not shown). These results strongly suggest that M2 is targeted directly to the apical domain without appearing transiently on the basolateral surface, similar to the direct apical transport of HA. The M2 protein appears on the plasma membrane at a slightly slower rate than HA, which could be due to a difference in the oligomerization rate of M2 (15, 48) and HA (12) or in the rate of their transport to the plasma membrane.
Polarized expression of M2 from a recombinant vaccinia virus. The observation that M2 expression is predominantly restricted to apical surfaces of influenza virus-infected cells raised the question whether M2 is directionally transported in the absence of other viral proteins, as has been shown for the influenza virus glycoproteins, HA and neuraminidase (20, 46 cell surface expression was investigated in filter-grown monkey kidney cells infected with the VV-M2 virus using 125I-labeled antibody binding (Fig. 6) Ultrastructural localization of M2 in influenza virus-infected cells. The localization of the M2 protein in influenza virusinfected MDCK cells was examined at the ultrastructural level using immunoelectron microscopy. At 7 h p.i., a time when extensive virus budding was occurring, the cells were labeled at 4°C with M2-specific monoclonal antibody and a gold probe (Fig. 7) . For comparison, virus-infected cells were also labeled with monoclonal antibodies specific for HA or an unrelated protein and the gold probe. M2-specific labeling was observed on apical membranes, including microvilli of influenza virus-infected MDCK cells. In addition, gold particles were associated with fully assembled and released virions and were close to both cell membranes and budding virions. Infected cells labeled with HA-specific antibody exhibited similar distributions of gold particles (Fig. 7) . No labeling was observed on basolateral surfaces of filter-grown MDCK cells reacted with M2 antibody and secondary antibody conjugated with gold or ferritin (data not shown). The specificity of the immunolabeling reagents was demonstrated by the lack of significant binding of M2 antibody to uninfected-cell surfaces or of the gold probe to infected cells in the absence of influenza virus-specific antibody or in the presence of an unrelated antibody specific for the HA-neuraminidase protein (42) of parainfluenza type 3 virus (data not shown).
The distribution of M2 label was determined by quantitating the number of gold particles associated with either cell membranes or budding influenza virus particles on MDCK cells labeled with M2 antibody at 7 h p.i. (Table 1 Specific structural features which correlate with directional transport have been recently identified in other protein molecules. A subset of membrane proteins that contain a covalently attached glycophosphatidylinositol residue is restricted to the apical domain of polarized epithelial cells (28) . A signal directing basolateral transport in MDCK cells is formed by a 14-residue, arginine-rich sequence located adjacent to the membrane in the polymeric Ig receptor cytoplasmic domain (8) . A mutated protein lacking this sequence was transported directly to the apical surface, while a chimeric protein containing the signal was redirected from the apical to basolateral surface. A different signal for basolateral transport was identified in a mutated influenza virus HA which was targeted directly to the basolateral domain of MDCK cells after a single cytoplasmic cysteine residue was changed to tyrosine (4) . Specific signals in the cytoplasmic domains of several other proteins, including the Fc receptor, lysosomal glycoprotein lgpl20, and low-density lipoprotein receptor, are required for basolateral expression in MDCK cells (18, 19) . The finding that mutated proteins lacking putative basolateral targeting signals are predominantly expressed on apical surfaces of MDCK cells suggests that basolateral signals are dominant over apical signals in kidney cells or that proteins which lack basolateral targeting signals are transported to apical surfaces by default (4, 8, 16, 18, 19) . The available evidence suggests a correlation between basolateral polarity and endocytosis of certain proteins (4, 8, 16, 18, 19, 35) that contain a critical tyrosine residue in cytoplasmic sequences that function as internalization signals (10, 21) . The mutation or deletion of specific cytoplasmic tyrosine residues profoundly alters the polarity and endocytosis of certain proteins (4, 18, 19, 27, 35) . It is now evident that cytoplasmic tyrosine residues are not sufficient for basolateral targeting, since we found that the M2 protein was predominantly restricted to the apical domain of polarized cells despite the presence of two or three cytoplasmic tyrosine residues (23, 29) in sequences that are similar to proposed internalization signals (10, 21) . Both the position of tyrosine in the cytoplasmic domain and the specific amino acids that surround tyrosine residues apparently influence the ability of these sequences to serve as targeting signals for endocytosis or basolateral transport (16, 18, 19, 21, 27) . Therefore, it is likely that the cytoplasmic (16a) , but it has not been determined whether M2 is internalized to a significant extent in the absence of antibody. Further analysis of the polarity and endocytosis of M2 and other proteins containing cytoplasmic tyrosines will be required to clarify relationships between these events.
The punctate immunofluorescence pattern observed for M2 on apical surfaces of influenza virus-infected MDCK cells was similar to that observed for HA. However, the slightly more diffuse fluorescence pattern observed for M2 appeared to reflect subtle differences in the ultrastructural localization of the two proteins with respect to budding virions, presumably due to differences in M2 and HA incorporation into virions (57) . Immunoelectron microscopy further localized M2 to microvilli and the surrounding apical cell membrane of virus-infected MDCK cells and to completely assembled and budding virions, which did not exhibit obvious differences in the frequency or density of M2 label. It was surprising that a large percentage of the M2 label was found to be virion-associated and that the apparent density of M2 label on viral and cellular membranes was roughly equivalent, considering the low level of M2 incorporation into virions (57) compared with the large number of molecules on the infected-cell membrane (24) . The restriction of M2 to the apical domain of polarized cells, which is the site of influenza virus budding, and the association of M2 with both cellular membranes and nascent virions are consistent with a possible role for M2 in virus assembly. However, the mechanism responsible for excluding the majority of M2 molecules from virions such that only a few molecules are incorporated during virus assembly is not known. As treatment of virions with the drug amantadine hydrochloride inhibits virus uncoating (5) , and the antiviral effect is exerted on M2 function (2, 14) , it is likely that the M2 molecules incorporated into virions play a role in viral infectivity.
It has been suggested that the M2 protein may be associated with an ion channel activity (47, 49) , and direct evidence for a pH-activated ion channel has been obtained by electrophysiological measurements of Xenopus laevis oocytes injected with M2 mRNA (41) . Alterations in the intracellular environment induced by M2 might affect virus assembly indirectly, as the late stages of protein transport are sensitive to ionic conditions (30, 47) . On the basis of the HA conformational changes that can occur in the presence of amantadine (47) , it was suggested that M2 influences the stability of HA trimers during transport and that M2 might function to offset intracellular pH changes induced by the shutdown of host protein synthesis during virus infection (34, 47) . Inhibition by amantadine might be due to an interaction between the drug and M2 in virion or cell membranes that alters the ion channel function of M2 (41) and may disrupt either early or late stages of replication (5, 14, 47, 49) . Current evidence suggests that M2 might function to influence interactions among virion components during virus entry or budding. A monoclonal antibody to the external domain of M2 inhibited influenza virus replication in a strain-specific manner (50, 57, 58) , and the mutation of specific residues in the cytoplasmic domain of M2 or in the Ml protein conferred resistance to the M2 antibody (58) . The mechanism that targets Ml to sites of virus budding is not yet known, but immunoelectron microscopic studies indicated that once Ml and the nucleocapsid associate with the plasma membrane, virus budding is rapidly completed (39) . The Ml protein is reported to associate spontaneously with lipids by inserting specific regions of the molecule into the bilayer (13, 56) , and the association of Ml with the virus envelope appears to be pH sensitive (60) . The present finding that M2 label was frequently associated with nascent virions is consistent with the hypothesis that the affinity of the Ml protein for the plasma membrane may be influenced by M2 ion channels or by a targeting signal in the M2 molecule. In addition, virion-associated M2 may facilitate uncoating in secondary endosomes by permitting a flux of ions into virions and altering interactions between Ml and the viral envelope or ribonucleoprotein complexes (5, 41, 60) . Therefore, it is conceivable that M2 may function, perhaps in a pH-sensitive mechanism, to regulate the association between internal virion components and the viral envelope during virus uncoating and assembly stages of replication.
